Answers are grounded in this paper and cite their sources.
Forum highlights cancer immunotherapy advancements and gathers experts in immunology, suggesting new strategies.
The Spanish Group for Cancer Immuno-Biotherapies (GÉTICA) held the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11) from 13 to 15 March 2025, in Madrid (Spain). FITCancer is the largest meeting uniquely focused on cancer immunotherapy in Spain and brings together clinicians and researchers with expertise in the field of cancer immunology and immunotherapy. Here, we present abstracts submitted by GÉTICA's members to the XI Forum on Translational Immunology and Cancer Immunotherapy, which were divided into the following three topics: novel therapeutic targets and strategies, cell-based immunotherapies, and clinical scenarios and potential biomarkers.
No takes yet. Share an insight, caveat, or question.
Aya et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: